Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.

Br J Clin Pharmacol · 2015 · PMC4309630 · PMID 25125025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

whereby drug interactions are likely to be significant when drug elimination occurs primarily through a single metabolic pathway 14 .

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.